News

1. Aesica Wins European Outsourcing Award For UCB Acquisition Strategy And Implementation 10/29/2012

   Aesica, the global contract manufacturing organisation (CMO), announces that it has won the European Outsourcing award for ‘best acquisition’ following the successful acquisition and integration of three different UCB sites – at Monheim and Zwickau in Germany, and Pianezza in Italy in 2011.

2. Pharmalink AB Receives Patent For Nefecon® Principle 10/26/2012

   Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD).

3. Pfenex Inc. Awards Althea Technologies A Contract For cGMP Manufacturing Of Circumsporozoite Protein From Plasmodium Falciparum, A Key Malaria Antigen 10/24/2012

   Pfenex Inc. recently announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine.

4. Dr. Reddy's Laboratories Limited Intends To Make A Recommended Public Offer For Octoplus N.V. 10/22/2012

   Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), together with its subsidiaries, announces the intended public offer to acquire the issued and outstanding shares of OctoPlus N.V. 

5. Novasep Invests EUR 30 Million To Build World's Largest Chromatography Plant For The Pharmaceutical Industry 10/10/2012

   Novasep, a leading provider of purificationbased manufacturing solutions for life science molecules, announces recently an investment of EUR 30 million to build in Europe what will be the world’s largest chromatography plant used for the production of a large volume commercial API (active pharmaceutical ingredient).

6. Dr. Reddy's Custom Pharmaceutical Services (CPS) Business Expands Its Manufacturing Operations In Mirfield, UK 10/8/2012

   The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. recently announced expansion in the areas of activated mPEG manufacturing and in the development and manufacture of NCE (New Chemical Entities) APIs for use in pre-clinical through to commercial development at its manufacturing facility in Mirfield, UK.